Zai Lab Ltd $ 53.1 1.44 (2.79%)
Volume:
412,414
Avg Vol (1m):
220,269
Market Cap $:
3.10 Bil
Enterprise Value $:
2.72 Bil
P/E (TTM):
0.00
P/B:
9.10
Financial Strength |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 29.42 | ||
| Equity-to-Asset | 0.88 | ||
| Debt-to-Equity | 0.03 | ||
| Debt-to-EBITDA | -0.07 | ||
| Piotroski F-Score | 5 | ||
| Altman Z-Score | 34.73 | ||
Profitability Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | -5259.26 | ||
| Net Margin % | -5096.03 | ||
| ROE % | -64.34 | ||
| ROA % | -56.56 | ||
| ROC (Joel Greenblatt) % | -775.64 | ||
| 3-Year EBITDA Growth Rate | -99.2 | ||
| 3-Year EPS without NRI Growth Rate | -74.7 |
Valuation Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PB Ratio | 9.1 | ||
| PS Ratio | 26550 | ||
| EV-to-EBIT | -15.12 | ||
| EV-to-EBITDA | -15.12 | ||
| EV-to-Revenue | 766.15 | ||
| Current Ratio | 8.74 | ||
| Quick Ratio | 8.74 | ||
| Days Inventory | 19.05 | ||
| Days Sales Outstanding | 255.37 | ||
| Days Payable | 10928.71 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.8 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 9.11 | ||
| Price-to-Median-PS-Value | 1.68 | ||
| Earnings Yield (Greenblatt) % | -6.61 |